Han Yu, Wennersten Sara A, Pandi Boomathi P, Ng Dominic C M, Lau Edward, Lam Maggie P Y
Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO 80045, USA.
bioRxiv. 2024 Apr 10:2024.04.09.588716. doi: 10.1101/2024.04.09.588716.
The fetal genetic program orchestrates cardiac development and the re-expression of fetal genes is thought to underlie cardiac disease and adaptation. Here, a proteomics ratio test using mass spectrometry is applied to find protein isoforms with statistically significant usage differences in the fetal vs. postnatal mouse heart. Changes in isoform usage ratios are pervasive at the protein level, with 104 significant events observed, including 88 paralog-derived isoform switching events and 16 splicing-derived isoform switching events between fetal and postnatal hearts. The ratiometric proteomic comparisons rediscovered hallmark fetal gene signatures including a postnatal switch from fetal β (MYH7) toward ɑ (MYH6) myosin heavy chains and from slow skeletal muscle (TNNI1) toward cardiac (TNNI3) troponin I. Altered usages in metabolic proteins are prominent, including a platelet to muscle phosphofructokinase (PFKP - PFKM), enolase 1 to 3 (ENO1 - ENO3), and alternative splicing of pyruvate kinase M2 toward M1 (PKM2 - PKM1) isoforms in glycolysis. The data also revealed a parallel change in mitochondrial proteins in cardiac development, suggesting the shift toward aerobic respiration involves also a remodeling of the mitochondrial protein isoform proportion. Finally, a number of glycolytic protein isoforms revert toward their fetal forms in adult hearts under pathological cardiac hypertrophy, suggesting their functional roles in adaptive or maladaptive response, but this reversal is partial. In summary, this work presents a catalog of ratiometric protein markers of the fetal genetic program of the mouse heart, including previously unreported splice isoform markers.
胎儿基因程序调控心脏发育,胎儿基因的重新表达被认为是心脏病及适应性变化的基础。在此,我们应用基于质谱的蛋白质组学比率测试,以寻找在胎儿与出生后小鼠心脏中具有统计学显著使用差异的蛋白质异构体。异构体使用比率的变化在蛋白质水平普遍存在,共观察到104个显著事件,包括88个旁系同源物衍生的异构体转换事件和16个胎儿与出生后心脏之间剪接衍生的异构体转换事件。比率蛋白质组学比较重新发现了标志性的胎儿基因特征,包括出生后从胎儿β(MYH7)向α(MYH6)肌球蛋白重链的转变,以及从慢骨骼肌(TNNI1)向心脏(TNNI3)肌钙蛋白I的转变。代谢蛋白的使用变化显著,包括糖酵解过程中血小板型到肌肉型磷酸果糖激酶(PFKP - PFKM)、烯醇化酶1到3(ENO1 - ENO3)的转变,以及丙酮酸激酶M2向M1(PKM2 - PKM1)异构体的可变剪接。数据还揭示了心脏发育过程中线粒体蛋白的平行变化,表明向有氧呼吸的转变也涉及线粒体蛋白质异构体比例的重塑。最后,在病理性心脏肥大的成年心脏中,一些糖酵解蛋白异构体恢复为胎儿形式,表明它们在适应性或适应不良反应中的功能作用,但这种逆转是部分的。总之,这项工作展示了小鼠心脏胎儿基因程序的比率蛋白质标记目录,包括以前未报道的剪接异构体标记。